Bansi Nagji - 19 Oct 2021 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
President, Healthcare
Signature
/s/ Gracye Cheng, as Attorney-in-Fact for Bansi Nagji
Issuer symbol
GDRX
Transactions as of
19 Oct 2021
Net transactions value
-$625,826
Form type
4
Filing time
21 Oct 2021, 16:52:16 UTC
Previous filing
12 Oct 2021
Next filing
27 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise $684 +100 $6.84 100 19 Oct 2021 Direct
transaction GDRX Class A Common Stock Sale $4,502 -100 -100% $45.02* 0 19 Oct 2021 Direct F1
transaction GDRX Class A Common Stock Options Exercise $111,492 +16,300 $6.84 16,300 20 Oct 2021 Direct
transaction GDRX Class A Common Stock Sale $733,500 -16,300 -100% $45.00* 0 20 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Stock Option (Right to Buy) Options Exercise $0 -100 -0.03% $0.000000 305,884 19 Oct 2021 Class A Common Stock 100 $6.84 Direct F2
transaction GDRX Stock Option (Right to Buy) Options Exercise $0 -16,300 -5.3% $0.000000 289,584 19 Oct 2021 Class A Common Stock 16,300 $6.84 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.